Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-29Clinical Trial Update: Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected Patients [Phase 1]
Phase 1 study evaluating a novel Ad6NSmut/MVA-NSmut therapeutic vaccine for chronic Hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-29Clinical Trial Update: A Phase 1 Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Hepatic Function and Moderate or Severe Hepatic Impairment [Phase 1]
A Phase 1 pharmacokinetics study evaluated how normal, moderate, and severe hepatic impairment affects exposure to velpatasvir (GS-5816) in …
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 Infection [Phase 2]
A Phase 2 dose-ranging trial assessed PF-00868554 in combination with Pegasys and Copegus for chronic hepatitis C genotype 1; results from t…
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: HCV Treatment With Fluvastatin, Simvastatin to Improve Interferon Sensitivity [Phase 1]
A Phase 1 trial testing whether adding fluvastatin and simvastatin to interferon can improve interferon sensitivity in chronic hepatitis C w…
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV Patients [Phase 2]
Phase 2 trial evaluating TG4040 therapeutic vaccine in combination with pegylated interferon and ribavirin shows efficacy signals in chronic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C [Phase 1]
Phase 1 study evaluating GS-9620 in treatment-naive subjects with chronic hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: Characterization of Clonal B Cell Populations in HCV Infection
A completed clinical trial characterized clonal B cell populations in Hepatitis C infection to understand immune features associated with ch…
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: Hepatitis C Virus and the Humoral Immune System
A completed clinical trial update examining the interaction between Hepatitis C virus and the humoral immune system.
-
CLINICAL_TRIALS trial_result · 2013-08-08Clinical Trial Update: Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients [Phase 3]
A Phase 3 trial comparing albumin-bound interferon alfa-2b plus ribavirin versus pegylated interferon alfa-2a plus ribavirin in interferon-n…
-
CLINICAL_TRIALS trial_result · 2013-08-08Clinical Trial Update: Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3 [Phase 3]
Phase 3 clinical trial comparing albumin-bound interferon alfa-2b plus ribavirin to pegylated interferon alfa-2a plus ribavirin in interfero…
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Increasing Viral Testing in the Emergency Department [Phase 2, Phase 3]
Phase 2 and Phase 3 clinical trials evaluated increasing viral testing in the emergency department, focusing on HIV and Hepatitis C testing …
-
CLINICAL_TRIALS trial_result · 2013-08-06Clinical Trial Update: A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects [Phase 3]
A multicenter Phase 3 trial evaluated interferon-beta-1a for chronic hepatitis C in Asian subjects. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3 [Phase 2]
A Phase 2 clinical trial update reporting completion of a study evaluating Albuferon in combination with ribavirin for treatment-naive chron…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C [Phase 2]
A Phase 2 study evaluating albuferon in combination with ribavirin for interferon-treatment experienced chronic hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-01Clinical Trial Update: Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin [Phase 4]
A Phase 4 trial evaluating acetyl-L-carnitine supplementation during hepatitis C therapy (pegylated interferon-α2b plus ribavirin) has compl…
-
CLINICAL_TRIALS trial_result · 2013-07-26Clinical Trial Update: Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin: Effect on Work Performance. [Phase 3]
A phase 3 trial evaluating whether adding acetyl-L-carnitine to standard hepatitis C therapy with pegylated interferon alfa-2b plus ribaviri…
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy
The completed trial evaluated whether FGL2/Fibroleukin status can predict response to antiviral therapy in chronic hepatitis C virus infecti…
-
CLINICAL_TRIALS trial_result · 2013-07-19Clinical Trial Update: A Randomized Trial of Vaccine Adherence in Young Injection Drug Users [NA]
This completed randomized trial examined adherence to vaccination among young injection drug users, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-07-12Clinical Trial Update: An Exploratory Study of Telaprevir in Treatment-Naive Participants With Chronic Genotype 4 Hepatitis C Virus Infection [Phase 2]
An update on a Phase 2 exploratory trial of telaprevir in treatment-naive adults with chronic genotype 4 hepatitis C, with results posted.
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Trial Comparing the Efficacy, Tolerability and Safety Between Three Arms in Treatment of HCV in Egyptian Population [Phase 4]
This is a Phase 4 clinical trial update comparing three treatment arms for chronic hepatitis C in an Egyptian population; the available snip…
-
CLINICAL_TRIALS trial_result · 2013-07-09Clinical Trial Update: Potential for Drug-drug Interactions Between Boceprevir and Etravirine in HIV/Hepatitis C Virus Negative Volunteers [NA]
Completed trial evaluating potential drug-drug interactions between boceprevir and etravirine in HIV/Hepatitis C-negative volunteers.
-
CLINICAL_TRIALS trial_result · 2013-07-05Clinical Trial Update: S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C [Phase 2]
A Phase 2 study sponsored by NIDDK evaluated S-Adenosyl Methionine (SAMe) for chronic hepatitis C; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C [Phase 3]
Phase 3 trial update of PEDS-C evaluating pegylated interferon with or without ribavirin in children with chronic hepatitis C; study complet…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: A Registration Study to Evaluate the Performance of CHIRON® RIBA® HCV 3.0 SIA in HCV Antibody Detection
A registration study evaluating the CHIRON RIBA HCV 3.0 SIA diagnostic for Hepatitis C antibody detection has been terminated in China. The …
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: A Study of Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response [Phase 3]
Phase 3 study assessing the combination of Pegasys (pegylated interferon alfa-2a) and Copegus (ribavirin) in patients with chronic hepatitis…